RUA Life Sciences plc (AIM:RUA)
London · Delayed Price · Currency is GBP · Price in GBX 25.55
-0.95 (-3.58%)
Aug 17, 2026, 4:00 PM GMT
RUA Life Sciences Cash Flow Statement
Financials in millions GBP. Fiscal year is October - September.
Millions GBP. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 0.28 | -0.15 | 0 | -1.44 | -2 | -2.07 |
Depreciation & Amortization | 0.44 | 0.44 | 0.42 | 0.36 | 0.36 | 0.31 |
Other Amortization | - | - | - | - | - | 0 |
Loss (Gain) From Sale of Assets | -0.6 | -0.6 | - | - | - | - |
Stock-Based Compensation | 0.11 | 0.11 | 0.11 | -0.04 | 0.1 | 0.15 |
Other Operating Activities | -0.15 | -0.03 | -0.93 | -0.5 | -0.3 | -0.29 |
Change in Accounts Receivable | -0.47 | 0.01 | 0.18 | -0.36 | 0.33 | -0.05 |
Change in Inventory | -0.24 | -0.14 | 0 | -0.03 | 0.04 | -0.04 |
Change in Accounts Payable | -0.37 | 0.12 | 0.01 | 0.1 | -0.2 | -0.45 |
Change in Income Taxes | 0.1 | 0.09 | -0.01 | 0.57 | 0.53 | 0.09 |
Operating Cash Flow | -0.9 | -0.13 | -0.22 | -1.33 | -1.15 | -2.35 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | -0.12 | -0.11 | -0.06 | -0.06 | -0.45 | -0.9 |
Sale of Property, Plant & Equipment | 0.01 | 0 | 0 | 0.03 | - | - |
Cash Acquisitions | 0.18 | 0.07 | 0.1 | - | - | - |
Other Investing Activities | 0.04 | 0.04 | 0.03 | -0.06 | -0.03 | -0.01 |
Investing Cash Flow | 0.11 | -0 | 0.07 | -0.09 | -0.48 | -0.91 |
Long-Term Debt Issued | - | - | 0.03 | 0.01 | 0.23 | - |
Total Debt Issued | 0.01 | 0.03 | 0.03 | 0.01 | 0.23 | - |
Long-Term Debt Repaid | - | - | -0.22 | -0.15 | -0.1 | -0.07 |
Total Debt Repaid | -0.38 | -0.39 | -0.22 | -0.15 | -0.1 | -0.07 |
Net Debt Issued (Repaid) | -0.37 | -0.36 | -0.2 | -0.14 | 0.13 | -0.07 |
Issuance of Common Stock | - | - | - | 3.97 | - | - |
Other Financing Activities | 0.05 | 0.05 | - | 0.05 | - | - |
Financing Cash Flow | -0.32 | -0.31 | -0.2 | 3.89 | 0.13 | -0.07 |
Foreign Exchange Rate Adjustments | -0.02 | -0.02 | -0.02 | -0.03 | 0.01 | - |
Net Cash Flow | -1.13 | -0.45 | -0.36 | 2.45 | -1.48 | -3.33 |
Free Cash Flow | -1.02 | -0.24 | -0.28 | -1.38 | -1.6 | -3.26 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -22.11% | -5.29% | -6.83% | -63.12% | -73.20% | -200.43% |
Free Cash Flow Per Share | -0.02 | -0.00 | -0.01 | -0.04 | -0.07 | -0.15 |
Levered Free Cash Flow | - | - | -0.05 | -1.25 | -1.01 | -2.72 |
Unlevered Free Cash Flow | - | - | -0.05 | -1.2 | -1 | -2.71 |
Cash Interest Paid | 0.04 | 0.05 | 0.05 | 0.06 | 0.03 | 0.01 |
Cash Income Tax Paid | - | - | 0.01 | - | - | - |
Change in Working Capital | -0.99 | 0.08 | 0.18 | 0.28 | 0.7 | -0.46 |